Treatment of Ulcerative Colitis with Olsalazine and Sulphasalazine: Efficacy and Side-Effects

The two‐period cross‐over clinical trial.

1979 • 1,402 citations

Adverse Reactions during Salicylazosulfapyridine Therapy and the Relation with Drug Metabolism and Acetylator Phenotype

1973 • 451 citations

Absorption, metabolism, and excretion of salicylazosulfapyridine in man

1972 • 329 citations

Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.

1980 • 327 citations

SULPHASALAZINE AND SALICYLAZOSULPHADIMIDINE IN ULCERATIVE COLITIS

1962 • 296 citations

Distribution Studies of Salicylazosulfapyridine and its Metabolites

1973 • 253 citations

Controlled trial of sulphasalazine in the treatment of ulcerative colitis

1964 • 251 citations

Sulfasalazine

1983 • 241 citations

Azodisal sodium in the treatment of ulcerative colitis

1986 • 197 citations

Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis.

1982 • 152 citations

Kinetics of 5‐aminosalicylic acid after jejunal instillation in man.

1983 • 136 citations

Olsalazine in active ulcerative colitis.

1985 • 117 citations

Disposition of disodium azodisalicylate in healthy subjects

1985 • 58 citations

Effect of azodisal sodium and sulphasalazine on ileostomy output of fluid and PGE2 and PGF2 alpha in subjects with a permanent ileostomy.

1986 • 48 citations

Chronic ulcerative colitis

1958 • 14 citations